| Category: | Medical & Pharma, Pharmaceuticals |
|---|---|
| Organizer: | Reed Exhibitions Japan Ltd. |
| Exhibition center: | Tokyo Big Sight - International Exhibition Center |
Hotels search near to Tokyo Big Sight - International Exhibition Center
Overview interest facts - In-Pharma Japan 2024
Asia's leading B-to-B ingredients trade show serving as the BEST business platform for pharmaceutical ingredients suppliers to expand sales and network in the Japanese pharmaceutical industry. Co-held with the world's leading exhibition for Pharmaceutical R&D and Manufacturing, in-PHARMA JAPAN is unrivalled in its ability to bring together every key person in the Japanese pharmaceutical market. Exhibit here and grab your chance in the world's second largest pharmaceutical market.
Overview of exhibitors / visitors - In-Pharma Japan 2024
Pharmaceutical Ingredients Japan will include participation of lots of exhibitors from all around the world. The exhibitors will include manufacturers, engineers, suppliers, dealers and all other professionals associated with the pharmaceutical industry; they can belong to departments like production, quality control, management, research and development; and marketing & sales. The various exhibiting products include APIs, Antibodies, Enzymes, Synthetic Substances, Antibiotics, Fine Chemicals, Additives, and Excipients such as Antimicrobial Preservatives, Emulsifying, Flavors, Ointments Bases, Suppository Agents, and Tablet Disintegrants.
Recommended events
Recommended events
News
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...
22 January 2024New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023FDA approves first oral treatment for postpartum depression
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.
10 August 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws
04 May 2023